1 Min Read
Oct 13 (Reuters) - Jubilant Life Sciences Ltd :
* Says Jubilant Life Sciences receives ANDA approval for Darifenacin ER tablets Source text: bit.ly/2dMoFFv Further company coverage: (Bengaluru newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.